Cartesian Therapeutics grants inducement stock options to five new employees

9 articles · Updated · The Manila Times · May 4

The May 1 awards cover 317,200 shares at an exercise price of $6.22, matching the stock's Nasdaq closing price that day.
The board approved the grants under the company's amended 2018 Employment Inducement Incentive Award Plan and Nasdaq Rule 5635(c)(4).
The options vest 25% on May 1, 2027, then monthly until fully vested on May 1, 2030, and carry a 10-year term.

Are these stock options a golden ticket for new hires or a high-risk bet on a company burning through cash?

Is Cartesian's hiring spree a sign of confidence, or a final gamble before its cash runway ends in mid-2027?